KALA BIO, Inc. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2ab0381b-6e9e-4086-a88b-630d31f81b3c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-27.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-043782 |
| FY 2024 | $-38.5M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-004081 |
| FY 2023 | $-42.2M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-004326 |
| FY 2022 | $-44.8M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002746 |
| FY 2021 | $-142.6M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004624 |
| FY 2020 | $-104.3M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001797 |
| FY 2019 | $-94.3M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-000733 |
| FY 2018 | $-66.7M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001825 |
| FY 2017 | $-42.2M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-002697 |
| FY 2016 | $-33.2M | 2016-01-01 – 2016-12-31 | evidence 0001558370-18-002697 |
| FY 2015 | $-16.7M | 2015-01-01 – 2015-12-31 | evidence 0001558370-18-002697 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).